穿膜肽GGPFV修饰的柔红霉素/薯蓣皂苷脂质体的处方优化及细胞毒性研究
x

请在关注微信后,向客服人员索取文件

篇名: 穿膜肽GGPFV修饰的柔红霉素/薯蓣皂苷脂质体的处方优化及细胞毒性研究
TITLE: Formulation Optimization and Cytotoxicity Study of GGPFV-modified Daunorubicin/dioscin Liposomes
摘要: 目的:制备穿膜肽GGPFV修饰的柔红霉素/薯蓣皂苷脂质体,对其处方进行优化,并初步评价其对乳腺癌细胞的体外毒性。方法:采用薄膜分散法和硫酸铵水化法,将柔红霉素和薯蓣皂苷包载其中,在表面以聚乙二醇-二硬脂酰基磷脂酰乙醇胺2000(DSPE-PEG2000)-GGPFV修饰,制备GGPFV修饰的柔红霉素/薯蓣皂苷脂质体。以包封率为指标,采用Box-Behnken响应面法优化处方中水化体积、胆固醇用量和柔红霉素用量;测定按最优处方制备的3批脂质体的包封率。比较柔红霉素/薯蓣皂苷脂质体、GGPFV修饰的柔红霉素/薯蓣皂苷脂质体和空白脂质体作用后对人乳腺癌MDA-MB-435S细胞存活率的影响。结果:最优处方为水化体积5mL、胆固醇4mg、蛋黄卵磷脂22mg、柔红霉素0.55mg、薯蓣皂苷0.85mg、DSPE-PEG20003.5mg、DSPE-PEG2000-GGP-FV2mg。所制3批脂质体中,柔红霉素的包封率为(96.21±1.54)%,薯蓣皂苷的包封率为(95.39±2.48)%。体外细胞毒性试验显示,GGPFV修饰的柔红霉素/薯蓣皂苷脂质体对MDA-MB-435S细胞的抑制作用显著强于柔红霉素/薯蓣皂苷脂质体(P<0.05),膜材无细胞毒性。结论:成功制得GGPFV修饰的柔红霉素/薯蓣皂苷脂质体,其对人乳腺癌MDA-MB-435S细胞的体外抑制作用明显增强。
ABSTRACT: OBJECTIVE:To prepare GGPFV-modified Daunorubicin/dioscin liposomes ,and to optimize their formulation and to preliminarily evaluate their cytotoxicity to breast cancer cells in vitro . METHODS :Daunorubicin and diosgenin were wrapped by thin film dispersion method and ammonium sulfate hydration method ;the surface was modified with DSPE-PEG2000-GGPFV to prepare GGPFV-modified Daunorubicin/dioscin liposomes. Taking encapsulation rate as index ,Box-Behnken response surface methodology was used to optimize the film hydration volume ,cholesterol amount and daunorubicin amount in the formulation. The entrapment efficiency of 3 batches of liposomes prepared according to the optimal formulation was determined. The effects of Daunorubicin/dioscin liposomes ,GGPFV-modified Daunorubicin/dioscin liposomes and blank liposomes on the survival rate of human breast cancer MDA-MB- 435S cells were compared. RESULTS :The optimal formulation was as film hydration volume of 5 mL,cholesterol of 4 mg,yolk lecithin of 22 mg,daunorubicin of 0.55 mg,dioscin of 0.85 mg,DSPE-PEG2000 of 3.5 mg, DSPE-PEG2000-GGPFV of 2 mg. The encapsulation rate of daunorubicin was (96.21±1.54)% and that of dioscin was (95.39± 2.48)% in the 3 batches of liposomes prepared. The in vitro cytotoxicity tests showed that the inhibition effect of GGPFV-modified Daunorubicin/dioscin liposome on MDA-MB-435S cells was significantly stronger than that of Daunorubicin/dioscin liposome (P< 0.05). There was no cytotoxicity in the membrane. CONCLUSIONS :GGPFV-modified Daunorubicin/dioscin liposomes are successfully prepared ,and its inhibitory effect on human breast cancer MDA-MB- 435S cells in vitro was significantly enhanced.
期刊: 2020年第31卷第21期
作者: 姚雪敏,荆鸣,蔡馥伊,孔亮,李学涛
AUTHORS: YAO Xuemin ,JING Ming,CAI Fuyi,KONG Liang,LI Xuetao
关键字: 脂质体;GGPFV;柔红霉素;薯蓣皂苷;处方优化;Box-Behnken响应面法;细胞毒性
KEYWORDS: Liposome;GGPFV;Daunorubicin;Dioscin;Formulation optimization ;Box-Behnken design response surface
阅读数: 132 次
本月下载数: 7 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!